| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-08 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-07 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |